Table 2 Clinical outcomes by L1CAM expression, by p53 expression, and by combined diffuse L1CAM expression and mutant p53 expression

From: Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer

 

L1CAM 0% (N=31)

L1CAM <10% (N=34)

L1CAM 10–50% (N=23)

L1CAM >50% (N=27)

P53-wild-type (N=74)

P53-mutant (N=41)

L1CAM >50% p53-mutant (N=18)

 

Events

%

Events

%

Events

%

Events

%

Events

%

Events

%

Events

%

Survival

 Alive

22

71.0

22

64.7

12

52.2

11

40.7

49

66.2

18

43.9

8

44.4

 Dead

9

29.0

12

35.3

11

47.8

16

59.3

25

33.8

23

56.1

10

55.6

Recurrence

 Overall

11

35.5

12

35.3

7

30.4

14

50.0

23

31.3

21

50.0

12

63.2

 Locoregional

3

9.7

4

12.1

2

9.5

5

18.5

8

10.8

6

15.8

4

22.2

 Distant

9

29.0

8

24.2

5

22.7

13

48.1

17

23.0

18

46.2

11

61.1

  1. Abbreviation: L1CAM, L1 cell adhesion molecule.